Avepoint Inc (AVPT)

Currency in USD
12.95
+0.35(+2.78%)
Closed·
12.950.00(0.00%)
·
AVPT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
12.5313.03
52 wk Range
11.4920.25
Key Statistics
Prev. Close
12.95
Open
12.61
Day's Range
12.53-13.03
52 wk Range
11.49-20.25
Volume
1.3M
Average Volume (3m)
1.35M
1-Year Change
-28.92%
Book Value / Share
2.2
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AVPT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
19.19
Upside
+48.18%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

Avepoint Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Avepoint Inc Company Profile

AvePoint, Inc. provides cloud-native data management software platform in North America, Europe, the Middle East, Africa, and the Asia Pacific. It also offers platform-as-a-service architecture to address critical operational challenges and the management of data to organizations that leverage third-party cloud vendors, including Microsoft, Salesforce, Google, AWS, Box, DropBox, and others; license and support; and maintenance services. AvePoint, Inc. was incorporated in 2001 and is headquartered in Jersey City, New Jersey.

Employees
2934

Avepoint Inc Earnings Call Summary for Q3/2025

  • AvePoint reported Q3 2025 EPS of $0.06 (14.29% below forecast), while revenue reached $109.7M (3.77% above expectations), leading to a 3.15% stock decline to $14.28.
  • SaaS revenue grew 38% year-over-year to $84M (77% of total revenue), with total ARR increasing 26% to $390M and net new ARR of $22.4M.
  • The company projects Q4 revenue between $110-112M and targets full-year ARR of $412.8-418.8M, with a long-term goal of $1B in ARR by 2029.
  • CEO Dr. Tj Jiang highlighted that 86% of organizations have delayed AI rollouts due to security concerns, positioning AvePoint's AI governance solutions as strategic priorities.
  • AvePoint faces challenges including public sector uncertainty affecting the federal segment and potential impacts of government shutdowns on ARR guidance.
Last Updated: 07/11/2025, 00:18
Read Full Transcript

Compare AVPT to Peers and Sector

Metrics to compare
AVPT
Peers
Sector
Relationship
P/E Ratio
1,418.5x−14.1x11.7x
PEG Ratio
12.25−0.680.01
Price/Book
6.0x5.2x2.4x
Price / LTM Sales
7.1x3.9x2.2x
Upside (Analyst Target)
39.0%33.3%28.0%
Fair Value Upside
Unlock13.6%5.5%Unlock

Analyst Ratings

10 Buy
3 Hold
0 Sell
Ratings:
13 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 19.19
(+48.18% Upside)

Earnings

Latest Release
Nov 06, 2025
EPS / Forecast
0.06 / 0.07
Revenue / Forecast
109.70M / 105.71M
EPS Revisions
Last 90 days

AVPT Income Statement

People Also Watch

47.470
IREN
-2.10%
13.4000
EOSE
+2.13%
144.78
ALAB
-2.01%
18.030
ZETA
+3.15%
71.29
CRWV
-3.14%

FAQ

What Stock Exchange Does Avepoint Trade On?

Avepoint is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Avepoint?

The stock symbol for Avepoint is "AVPT."

What Is the Avepoint Market Cap?

As of today, Avepoint market cap is 2.79B.

What Is Avepoint's Earnings Per Share (TTM)?

The Avepoint EPS (TTM) is 0.01.

When Is the Next Avepoint Earnings Date?

Avepoint will release its next earnings report on 25 Feb 2026.

From a Technical Analysis Perspective, Is AVPT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Avepoint Stock Split?

Avepoint has split 0 times.

How Many Employees Does Avepoint Have?

Avepoint has 2934 employees.

What is the current trading status of Avepoint (AVPT)?

As of 26 Nov 2025, Avepoint (AVPT) is trading at a price of 12.95, with a previous close of 12.95. The stock has fluctuated within a day range of 12.53 to 13.03, while its 52-week range spans from 11.49 to 20.25.

What Is Avepoint (AVPT) Price Target According to Analysts?

The average 12-month price target for Avepoint is USD19.18892, with a high estimate of USD26 and a low estimate of USD16. 10 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +48.18% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.